I. Vachier et al., GLUCOCORTICOIDS INDUCED DOWN-REGULATION OF GLUCOCORTICOID RECEPTOR MESSENGER-RNA EXPRESSION IN ASTHMA, Clinical and experimental immunology, 103(2), 1996, pp. 311-315
Although their precise mechanism of action remains to be elucidated, g
lucocorticoids represent the most effective therapy in the treatment o
f asthma. Interactions between the glucocorticoid receptor and the AP-
1 complex have been shown to regulate the transcription of some genes,
including glucocorticoid receptor itself. The aim of the present stud
y was to compare the expression of mRNA for glucocorticoid receptor in
human blood monocytes obtained from seven unstable untreated asthmati
c patients who were subsequently treated with high doses of parenteral
corticosteroid (methyl prednisolone 120 mg/day) for 10 days. mRNA exp
ression was identified after RNA extraction using RNAzol and analysed
after reverse transcriptase, by polymerase chain reaction using a semi
quantitative competitive hybridization assay. All asthmatic patients s
howed an improvement in their FEV(1) values after corticosteroid treat
ment (per cent of predicted value 68.28 +/- 4.93 versus 95.57 +/- 6.41
, P < 0.02), and a significant decrease for glucocorticoid receptor mR
NA expression (P < 0.02) was observed in their monocytes. This is the
first report of an ex vivo down-regulation for the glucocorticoid rece
ptor mRNA expression, following corticosteroid treatment.